EUVIMEDEUVIMED entdecken
Crossref

Comparison of the inhibitory properties of the fruit component naringenin and its glycosides against OATP1A2 genetic variants

Naoya Araki, Tokio Morita, Takeshi Akiyoshi, Hiroki Kataoka, Kodai Yajima, Kazuhiro Katayama, Ayuko Imaoka, Hisakazu Ohtani

Drug Metabolism and Pharmacokinetics · 2022-10 · 46 · 100464

DOI: 10.1016/j.dmpk.2022.100464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Pharmacokinetics, 2022-10. Verfasst von Naoya Araki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Ja…. Hauptthemen laut MEDLINE: Flavanones, Organic Anion Transporters. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-synonymous genetic variants of organic anion-transporting polypeptide (OATP) 1A2 with altered transport activity have been identified. Naringin and narirutin, which are found in grapefruit, and their aglycon naringenin inhibit OATP1A2. However, their inhibitory effects on OATP1A2 variants have not been investigated, nor has the influence of their molecular structure, such as the number of sugar moieties, on their inhibitory potency. This study aimed to investigate the inhibitory effects of naringenin, its monosaccharide glycoside prunin, and its disaccharide glycosides naringin and narirutin on fexofenadine (FEX) uptake by OATP1A2 variants (Ile13Thr, Asn128Tyr, Ala187Thr, and Thr668Ser). Naringin, narirutin, and prunin inhibited FEX (0.3 μM) uptake by all of the examined OATP1A2 variants in a concentration-dependent manner. Compared with those for the wild type, the inhibition constants (Ki) of naringin, narirutin, and prunin for the Ala187Thr variant were significantly increased by 3.36-fold, 7.55-fold, and 10.6-fold, respectively. Naringenin inhibited all of the OATP1A2 variants, except Ala187Thr, concentration-dependently. The order of inhibitory potency was as follows for all variants: aglycone > monosaccharide glycoside > disaccharide glycosides. These results suggest that the Ala187Thr variant is less vulnerable to inhibition by naringenin and its glycosides. Moreover, greater glycosylation of naringenin reduces its inhibitory potency against OATP1A2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesOrganic Anion TransportersGlycosidesFruitDisaccharidesPeptidesMonosaccharidesAnionsTerfenadine

Stichwörter der Autor:innen

Citrus fruitsFood-drug interactionGenetic variantsNaringeninNaringinNarirutinOATP1A2Prunin

Substanzen

GlycosidesFlavanonesOrganic Anion TransportersDisaccharidesPeptidesMonosaccharidesAnionsnaringeninfexofenadineTerfenadine

Autor:innen und Institutionen

  • Division of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan. Electronic address: naoya-araki-708@keio.jp.
  • Division of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan. Electronic address: morita.tokio@keio.jp.
  • Division of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan; Department of Clinical Pharmacy, Keio University School of Medici…
  • Division of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan. Electronic address: kataoka-hrk@keio.jp.
  • Division of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan. Electronic address: kodai.ss-kp8181@keio.jp.
  • Division of Molecular Targeting Therapeutics, School of Pharmacy, Nihon University, 7-7-1, Narashinodai, Funabashi-shi, Chiba, 274-8555, Japan. Electronic address: katayama.kazuhiro@nihon-u.ac.jp.

Zitieren

APA

Araki, N., Morita, T., Akiyoshi, T., Kataoka, H., Yajima, K., Katayama, K., Imaoka, A., & Ohtani, H. (2022). Comparison of the inhibitory properties of the fruit component naringenin and its glycosides against OATP1A2 genetic variants. Drug Metabolism and Pharmacokinetics, 46, 100464. https://doi.org/10.1016/j.dmpk.2022.100464

Vancouver

Araki N, Morita T, Akiyoshi T, Kataoka H, Yajima K, Katayama K, et al. Comparison of the inhibitory properties of the fruit component naringenin and its glycosides against OATP1A2 genetic variants. Drug Metabolism and Pharmacokinetics. 2022;46:100464. doi:10.1016/j.dmpk.2022.100464

BibTeX
@article{Araki2022,
  author = {Araki, Naoya and Morita, Tokio and Akiyoshi, Takeshi and Kataoka, Hiroki and Yajima, Kodai and Katayama, Kazuhiro and Imaoka, Ayuko and Ohtani, Hisakazu},
  title = {Comparison of the inhibitory properties of the fruit component naringenin and its glycosides against OATP1A2 genetic variants},
  journal = {Drug Metabolism and Pharmacokinetics},
  year = {2022},
  volume = {46},
  pages = {100464},
  doi = {10.1016/j.dmpk.2022.100464}
}
Kostenlos starten →